{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Gene Therapy Agent" in comments (approximate match)
Status:
Investigational
Source:
NCT00642018: Phase 2 Interventional Completed Prostate Cancer
(2008)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00306904: Phase 2 Interventional Completed Diabetic Macular Edema
(2006)
Source URL:
Class:
NUCLEIC ACID
Status:
US Previously Marketed
Source:
VITRAVENE PRESERVATIVE FREE by NOVARTIS
(1998)
Source URL:
First approved in 1998
Source:
VITRAVENE PRESERVATIVE FREE by NOVARTIS
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02144051: Phase 1 Interventional Completed Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
(2014)
Source URL:
Class:
CONCEPT
Status:
Other
Class:
CONCEPT